Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 17, 2009

Premium

Richard Rava has joined Artemis Health as senior vice president of research and development, a new position at the firm. Rava comes to Artemis from Affymetrix, where he was a scientific co-founder and most recently senior vice president of research and development.


Joseph Blanchard will take over as chief operating officer at Aushon Biosystems. Blanchard previously was senior vice president of business development and strategy at Decision Biomarkers, and he has spent over 20 years in the life sciences field, Aushon said last week.


Agendia has tapped Alan Carter to serve as its new vice president of global business development. Carter formerly served as an executive at BioTrove, Celera, Applied Biosystems, and PerkinElmer. At Agendia, Carter will handle strategic business opportunities for the company's molecular diagnostics portfolio.


RainDance Technologies has named Patrick Kelly to the newly created position of European sales director. Kelly, based in Manchester, UK, joins the firm from Helicos Biosciences where he was global business manager for the company's European operations. He has also held European sales positions for Agilent Technologies, Affymetrix, and Applied Biosystems.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more